Parenteral Nutrition Market
PUBLISHED: 2025 ID: SMRC28485
SHARE
SHARE

Parenteral Nutrition Market

Parenteral Nutrition Market Forecasts to 2030 - Global Analysis By Product Type (Total Parenteral Nutrition (TPN) and Partial Parenteral Nutrition (PPN)), Nutrient Type, Route of Administration, Application, End User and By Geography

4.9 (32 reviews)
4.9 (32 reviews)
Published: 2025 ID: SMRC28485

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Parenteral Nutrition Market is accounted for $7.5 billion in 2024 and is expected to reach $11.4 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Parenteral nutrition (PN) is a medical treatment that provides essential nutrients directly into the bloodstream, bypassing the digestive system. This is typically used for patients who cannot absorb nutrients through normal eating due to conditions like gastrointestinal disorders, surgeries, or severe malnutrition. PN delivers a customized mixture of carbohydrates, proteins, fats, vitamins, and minerals through an intravenous line, ensuring the patient receives adequate nutrition for recovery and maintenance of body functions. It can be short-term or long-term depending on the patient's needs.
 
According to the U.S. Centers for Disease Control and Prevention (CDC), the preterm birth rate in the country was approximately 10.4% in 2022. In addition, during the same period, the preterm birth rate for African American women was around 14.6%.

Market Dynamics: 

Driver: 

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, diabetes, and gastrointestinal disorders, is driving the growth of the market. These conditions often impair nutrient absorption, necessitating intravenous nutrient support. As more patients require tailored nutrition to manage malnutrition and recovery, the demand for parenteral nutrition solutions increases. This trend is prompting innovations in the formulations and improving patient outcomes, thus expanding the market.

Restraint:

Limited reimbursement coverage

Limited reimbursement coverage for parenteral nutrition presents a significant challenge in the market, hindering access for many patients who need long-term nutritional support. Insufficient insurance reimbursement can lead to high out-of-pocket costs, making the treatment financially burdensome. This restricts patient access to essential care, particularly for those with chronic illnesses or in home healthcare settings. Consequently, the lack of adequate coverage can delay treatment and negatively impact patient outcomes.

Opportunity:

Growing demand for home healthcare

The growing demand for home healthcare is contributing to the expansion of the market. Patients requiring long-term nutritional support are increasingly being treated at home, reducing hospital stays and healthcare costs. Advances in home administration, including portable infusion pumps and improved formulations, are making it safer and more convenient for patients. This shift toward home healthcare is driving greater adoption of parenteral nutrition among individuals with chronic conditions.

Threat:

High cost of parenteral nutrition

The high cost of parenteral nutrition (PN) poses a significant barrier to its widespread adoption, particularly for patients without adequate insurance coverage. The expensive nature of the treatments, including specialized formulas, equipment, and healthcare support, can lead to financial strain on patients and healthcare systems. This can result in delayed treatments or limited access, especially in low-income populations, ultimately affecting patient outcomes and increasing healthcare disparities.

Covid-19 Impact: 

The COVID-19 pandemic had a profound impact on the market, increasing demand due to the rise in severe malnutrition and gastrointestinal complications among COVID-19 patients. The healthcare system's focus on critical care further heightened the need for home-based PN as hospitals were overwhelmed. However, disruptions in supply chains and shortages of key ingredients initially affected availability. Despite these challenges, the pandemic accelerated the adoption of home healthcare solutions for long-term nutritional support.
 
The amino acids segment is expected to be the largest during the forecast period

The amino acids segment is expected to account for the largest market share during the forecast period as they are essential building blocks for protein synthesis and overall body function. In formulations, amino acids are provided intravenously to support patients who cannot absorb nutrients orally. Customized amino acid solutions are tailored to meet the specific needs of individuals, especially those with chronic conditions, ensuring proper recovery, maintaining muscle mass, and preventing malnutrition.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate as they are primary settings for administering to patients with severe malnutrition, gastrointestinal disorders, or recovery from surgeries. Hospitals use specialized formulations to meet the nutritional needs of critically ill patients who cannot absorb nutrients orally. The demand in hospitals continues to grow due to the increasing prevalence of chronic diseases and complex medical conditions requiring nutritional support.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by the rising prevalence of chronic diseases, an aging population, and increasing demand for home healthcare solutions. The region's advanced healthcare infrastructure, along with innovations in PN formulations and delivery methods, further fuels market expansion. Additionally, strong reimbursement policies and a focus on improving patient outcomes are contributing to the growing adoption in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. There is growing awareness of parenteral nutrition in the healthcare community, with better diagnostic tools and a rising understanding of the importance of nutrition in managing various medical conditions. Additionally, several governments in the region are focusing on improving healthcare access and nutrition, especially in developing countries. This creates a conducive environment for the growth of the market.

Key players in the market

Some of the key players in Parenteral Nutrition market include AbbVie Inc., Baxter International Inc., Merck & Co., Danone Nutricia, Medi Pharma, Eli Lilly and Company, Aptalis Pharma, Sodium Bicarbonate LLC, Biomarin Pharmaceutical, B. Braun Melsungen AG, Smith & Nephew, Roche Holding AG, Novartis International AG, Medtronic and Orion Corporation.

Key Developments:

In June 2024, AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development.

In May 2024, Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. 

Product Types Covered:
• Total Parenteral Nutrition (TPN)
• Partial Parenteral Nutrition (PPN)

Nutrient Types Covered:
• Amino Acids
• Carbohydrates
• Lipids
• Vitamins & Minerals
• Trace Elements

Route of Administrations Covered:
• Central Parenteral Nutrition (CPN)
• Peripheral Parenteral Nutrition (PPN)

Applications Covered:
• Cancer
• Gastrointestinal Disorders
• Neurological Disorders
• Critical Care
• Pediatrics/Neonates
• Liver Disease
• Other Applications

End Users Covered:
• Hospitals
• Homecare
• Long-Term Care Facilities
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary        
          
2 Preface         

 2.1 Abstract        
 2.2 Stake Holders       
 2.3 Research Scope       
 2.4 Research Methodology      
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources       
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions      
          
3 Market Trend Analysis       
 3.1 Introduction       
 3.2 Drivers        
 3.3 Restraints       
 3.4 Opportunities       
 3.5 Threats        
 3.6 Application Analysis      
 3.7 End User Analysis       
 3.8 Emerging Markets       
 3.9 Impact of Covid-19       
          
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes      
 4.4 Threat of new entrants      
 4.5 Competitive rivalry       
          
5 Global Parenteral Nutrition Market, By Product Type    
 5.1 Introduction       
 5.2 Total Parenteral Nutrition (TPN)     
 5.3 Partial Parenteral Nutrition (PPN)     
          
6 Global Parenteral Nutrition Market, By Nutrient Type    
 6.1 Introduction       
 6.2 Amino Acids       
 6.3 Carbohydrates       
 6.4 Lipids        
 6.5 Vitamins & Minerals      
 6.6 Trace Elements       
          
7 Global Parenteral Nutrition Market, By Route of Administration   
 7.1 Introduction       
 7.2 Central Parenteral Nutrition (CPN)     
 7.3 Peripheral Parenteral Nutrition (PPN)     
          
8 Global Parenteral Nutrition Market, By Application     
 8.1 Introduction       
 8.2 Cancer        
 8.3 Gastrointestinal Disorders      
 8.4 Neurological Disorders      
 8.5 Critical Care       
 8.6 Pediatrics/Neonates      
 8.7 Liver Disease       
 8.8 Other Applications       
          
9 Global Parenteral Nutrition Market, By End User     
 9.1 Introduction       
 9.2 Hospitals        
 9.3 Homecare       
 9.4 Long-Term Care Facilities      
 9.5 Other End Users       
          
10 Global Parenteral Nutrition Market, By Geography     
 10.1 Introduction       
 10.2 North America       
  10.2.1 US       
  10.2.2 Canada       
  10.2.3 Mexico       
 10.3 Europe        
  10.3.1 Germany       
  10.3.2 UK       
  10.3.3 Italy       
  10.3.4 France       
  10.3.5 Spain       
  10.3.6 Rest of Europe      
 10.4 Asia Pacific       
  10.4.1 Japan       
  10.4.2 China       
  10.4.3 India       
  10.4.4 Australia       
  10.4.5 New Zealand      
  10.4.6 South Korea      
  10.4.7 Rest of Asia Pacific      
 10.5 South America       
  10.5.1 Argentina      
  10.5.2 Brazil       
  10.5.3 Chile       
  10.5.4 Rest of South America     
 10.6 Middle East & Africa      
  10.6.1 Saudi Arabia      
  10.6.2 UAE       
  10.6.3 Qatar       
  10.6.4 South Africa      
  10.6.5 Rest of Middle East & Africa     
          
11 Key Developments        
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 11.2 Acquisitions & Mergers      
 11.3 New Product Launch      
 11.4 Expansions       
 11.5 Other Key Strategies      
          
12 Company Profiling        
 12.1 AbbVie Inc.       
 12.2 Baxter International Inc.      
 12.3 Merck & Co.       
 12.4 Danone Nutricia       
 12.5 Medi Pharma       
 12.6 Eli Lilly and Company      
 12.7 Aptalis Pharma       
 12.8 Sodium Bicarbonate LLC      
 12.9 Biomarin Pharmaceutical      
 12.10 B. Braun Melsungen AG      
 12.11 Smith & Nephew       
 12.12 Roche Holding AG       
 12.13 Novartis International AG      
 12.14 Medtronic       
 12.15 Orion Corporation       
          
List of Tables         
1 Global Parenteral Nutrition Market Outlook, By Region (2022-2030) ($MN)  
2 Global Parenteral Nutrition Market Outlook, By Product Type (2022-2030) ($MN)  
3 Global Parenteral Nutrition Market Outlook, By Total Parenteral Nutrition (TPN) (2022-2030) ($MN)
4 Global Parenteral Nutrition Market Outlook, By Partial Parenteral Nutrition (PPN) (2022-2030) ($MN)
5 Global Parenteral Nutrition Market Outlook, By Nutrient Type (2022-2030) ($MN)  
6 Global Parenteral Nutrition Market Outlook, By Amino Acids (2022-2030) ($MN)  
7 Global Parenteral Nutrition Market Outlook, By Carbohydrates (2022-2030) ($MN)  
8 Global Parenteral Nutrition Market Outlook, By Lipids (2022-2030) ($MN)  
9 Global Parenteral Nutrition Market Outlook, By Vitamins & Minerals (2022-2030) ($MN) 
10 Global Parenteral Nutrition Market Outlook, By Trace Elements (2022-2030) ($MN)  
11 Global Parenteral Nutrition Market Outlook, By Route of Administration (2022-2030) ($MN) 
12 Global Parenteral Nutrition Market Outlook, By Central Parenteral Nutrition (CPN) (2022-2030) ($MN)
13 Global Parenteral Nutrition Market Outlook, By Peripheral Parenteral Nutrition (PPN) (2022-2030) ($MN)
14 Global Parenteral Nutrition Market Outlook, By Application (2022-2030) ($MN)  
15 Global Parenteral Nutrition Market Outlook, By Cancer (2022-2030) ($MN)  
16 Global Parenteral Nutrition Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN) 
17 Global Parenteral Nutrition Market Outlook, By Neurological Disorders (2022-2030) ($MN) 
18 Global Parenteral Nutrition Market Outlook, By Critical Care (2022-2030) ($MN)  
19 Global Parenteral Nutrition Market Outlook, By Pediatrics/Neonates (2022-2030) ($MN) 
20 Global Parenteral Nutrition Market Outlook, By Liver Disease (2022-2030) ($MN)  
21 Global Parenteral Nutrition Market Outlook, By Other Applications (2022-2030) ($MN) 
22 Global Parenteral Nutrition Market Outlook, By End User (2022-2030) ($MN)  
23 Global Parenteral Nutrition Market Outlook, By Hospitals (2022-2030) ($MN)  
24 Global Parenteral Nutrition Market Outlook, By Homecare (2022-2030) ($MN)  
25 Global Parenteral Nutrition Market Outlook, By Long-Term Care Facilities (2022-2030) ($MN) 
26 Global Parenteral Nutrition Market Outlook, By Other End Users (2022-2030) ($MN) 
          
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials